company background image
ALMIB logo

Amoéba ENXTPA:ALMIB Stock Report

Last Price

€0.41

Market Cap

€20.3m

7D

0.4%

1Y

-35.5%

Updated

27 Mar, 2024

Data

Company Financials +

ALMIB Stock Overview

Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water treatment, human wounds, and plant protection.

ALMIB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Amoéba S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amoéba
Historical stock prices
Current Share Price€0.41
52 Week High€0.74
52 Week Low€0.36
Beta-0.0045
1 Month Change-5.43%
3 Month Change7.62%
1 Year Change-35.51%
3 Year Change-83.78%
5 Year Change-81.60%
Change since IPO-95.44%

Recent News & Updates

Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Oct 14
Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Recent updates

Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Oct 14
Amoéba (EPA:ALMIB) Is Carrying A Fair Bit Of Debt

Is Amoéba (EPA:ALMIB) A Risky Investment?

Apr 28
Is Amoéba (EPA:ALMIB) A Risky Investment?

Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Oct 20
Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Apr 29
Does Amoéba (EPA:ALMIB) Have A Healthy Balance Sheet?

Shareholder Returns

ALMIBFR ChemicalsFR Market
7D0.4%-0.4%0.4%
1Y-35.5%24.8%9.6%

Return vs Industry: ALMIB underperformed the French Chemicals industry which returned 24.9% over the past year.

Return vs Market: ALMIB underperformed the French Market which returned 10.6% over the past year.

Price Volatility

Is ALMIB's price volatile compared to industry and market?
ALMIB volatility
ALMIB Average Weekly Movement17.6%
Chemicals Industry Average Movement5.3%
Market Average Movement4.2%
10% most volatile stocks in FR Market9.8%
10% least volatile stocks in FR Market2.2%

Stable Share Price: ALMIB's share price has been volatile over the past 3 months.

Volatility Over Time: ALMIB's weekly volatility has increased from 11% to 18% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201022n/ahttps://amoeba-nature.com

Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water treatment, human wounds, and plant protection. It develops applications by exploiting the characteristics of the amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France.

Amoéba S.A. Fundamentals Summary

How do Amoéba's earnings and revenue compare to its market cap?
ALMIB fundamental statistics
Market cap€20.33m
Earnings (TTM)-€7.30m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALMIB income statement (TTM)
Revenue€0
Cost of Revenue€1.55m
Gross Profit-€1.55m
Other Expenses€5.75m
Earnings-€7.30m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.15
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio7.3%

How did ALMIB perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.